Research Articles

Davis SR, Jane F. A Practitioner's Toolkit for Managing the Menopause Climacteric 2014 17: 564-579

Gartoulla P, Islam MR, Bell RJ, Davis SR. Prevalence of menopausal symptoms in Australian women at midlife: a systemic review. Climacteric 2014 17: 529-539

Davis SR, Panjari M, Robinson P, Fradkin P, Bell RJ. Menopausal Symptoms in Breast Cancer survivors nearly 6 years after diagnosis. Menopause  2014 Oct 21 (10): 1075-1081

Robinson PJ, Bell RJ, Davis SR Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancer Maturitas 2014 79(3): 279-286

Davis SR, Evans AM, Humberstone A Application site affects the pharmacokinetics of topical testosterone applied to the axillae compared with the inner arm Clinical Therapeutics Clin Ther 2014 36:1395-1401

Davis SR, Panjari M, Robinson PJ, Fradkin P, Bell RJ. Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis. Menopause. 2014 Oct;21(10):1075-81

Panjari M, Robinson PJ, Davis SR, Schwarz M, Bell RJ. A comparison of the characteristics, treatment and outcome after 5 years, of Australian women aged 70 + with those aged < 70 years at the time of diagnosis of breast cancer. J Geriatr Oncol. 2014 Apr;5(2):141-7 Epub 2014 Jan 5

Bell RJ, Robinson PJ, Nazeem F, Panjari M, Fradkin P, Schwarz M, Davis SR. Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. J Cancer Surviv. 2014 Mar;8(1):1-8 Epub 2013 Aug 23

Fooladi E, Bell RJ, Jane F, Robinson PJ, Kulkarni J, Davis SR. Testosterone improves antidepressant- emergent loss of libido in women: findings from a randomized, double-blind, placebo-controlled trial. J Sex Med 2014 Mar;11(3):831-9

Bell RJ, Fradkin P, Robinson PJ, Schwarz M, Davis SR. Intended follow-up of women with breast cancer at low risk of recurrence and at least 5 years from diagnosis. Intern Med J 2014 Apr;44(4):332-8. Epub June 5 2013

Davis SR, Davison SL, Gavrilescu M, Searle K, Gogos A, Rossell SL, Egan GF, Bell RJ. Effects of testosterone on visuospatial function and verbal fluency in postmenopausal women: results from a functional magnetic resonance imaging pilot study. Menopause. 2014 Apr;21(4):410-4 Epub 2013

Kulkarni J, Berk M, Wang W, Mu L, Scarr E, van Rheenan TE, Worsley R, Gurvich C, Gavrilidis E, de Castella A, Davis SR. A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania. Psychoneuroendocrinology 2014; 43:52-6

Wang B, Kurniawan Pramono H, Cicuttini FM, Hanna F, Davis SR, Bell RJ, Wang  YY. Association between urinary C-telopeptide fragments of type II collagen and knee structure in middle-aged women without clinical knee disease. Osteoarth Cart. 2014 Aug;22(8):1136-41

Hussein M, Cicuttini FM, Bell RJ, Robinson PJ, Davis SR, Giles GG, Graves S, Wluka A, YY Wang. Incidence of total knee and hip replacement due to osteoarthritis in relation to circulating sex steroid hormone concentrations in women. Arthritis and Rheumatism 2014 Aug;66(8):2144-51

Fooladi E, Bell RJ, Whittaker AM, Davis SR. Women's expectations and experiences of hormone treatment for sexual dysfunction. Climacteric 2014 Jun 2:1-20 2014 Dec;17(6):674-81

Davis SR, Jane F, Robinson PJ, Davison SL, Worsley R, Maruff P, Bell RJ. Transdermal testosterone improves verbal learning and memory in postmenopausal women not on oestrogen therapy. Clinical Endocrinology 2014 Oct;81(4):621-8

Wierman ME, Arlt W, Basson R, Davis SR, et al. 'Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline' J Clin Endocrinol Metab. 2014 Oct;99(10):3489-510.

Review Articles

Worsley R, Bell RJ, Kulkarni J, Davis SR. The association between vasomotor symptoms and depression during perimenopause: a systematic review. Maturitas 2014 2014 Feb;77(2):111-7.

Davis SR. Reproductive endocrinology: Hormone therapy to treat menopause-breaking a taboo. Nat Rev Endocrinol. 2014 Jan;10(1):6-8

Worlsey R, Davis SR. Hirsutism. Medicine Today 2014; 15(2): 49-52

Lobo RA, Davis SR, De Villiers TJ, Gompel A, Henderson VW, Hodis HN, Lumsden MA, Mack WJ, Shapiro S and Baber RJ. Prevention of diseases after menopause Climacteric 2014 17: 1-17

Davis SR, Worsley R. Androgen Treatment of postmenopausal women. J Steroid Biochem Mol Biol 2014 142: 107-114

Wierman ME, Arlt W, Basson R, Davis SR, Miller KK, Murad MH, Rosner W, Santoro N. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. 2014 Oct;99(10):3489-510

Gartoulla P, Islam MR, Bell RJ, Davis SR. Prevalence of menopausal symptoms in Australian women at midlife: a systemic review. Climacteric 2014 17: 529-539